This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $75,764.68, is a delivery order for DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a firm fixed price pricing type and an ultimate completion date of December 19, 2024. This contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/19/25, 9:58 AM